Meta-Analysis Confirms the Deleterious Effects of Combined BRAFV600E and Telomerase Reverse Transcriptase Promoter Mutations on the Course and Mortality of Papillary Thyroid Carcinoma

Clinical Thyroidology May 2017, Vol. 29, No. 5: 176-179.


http://ift.tt/2puvbJe